A new self-adjustable glaucoma drainage device has been developed. And to test its efficacy and its safety, a pilot study is designed.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
10
Implantation of a self adjustable glaucoma drainage device
SwissVisio
Sali, Senegal
Safety
Type and rate of complications post-surgery
Time frame: 3 months
IOP reduction
IOP reduction by \>20%
Time frame: Baseline versus every visit, up to 1 year
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.